Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA)

CUSIP: 55234L105

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
1,644,695
Total 13F shares
7,656,403
Share change
+619,064
Total reported value
$85,729,000
Price per share
$11.18
Number of holders
39
Value change
+$6,831,936
Number of buys
16
Number of sells
22

Security key

55234L105

Report period

Q3 2020

Institutions

39

Top holders

10

Top shareholders of LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PERCEPTIVE ADVISORS LLC
13F
Company
196%
3,222,561
$36,543,000 30 Jun 2020
13F
Polaris Venture Management Co. V, L.L.C.
13F
Company
67%
1,100,852
$12,484,000 30 Jun 2020
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
50%
815,849
$9,252,000 30 Jun 2020
13F
CITADEL ADVISORS LLC
13F
Company
16%
255,794
$2,901,000 30 Jun 2020
13F
BlackRock Finance, Inc.
13F
Company
12%
205,260
$2,328,000 30 Jun 2020
13F
Invesco Ltd.
13F
Company
12%
200,882
$2,278,000 30 Jun 2020
13F
ArrowMark Colorado Holdings LLC
13F
Company
12%
200,180
$2,270,000 30 Jun 2020
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
12%
198,011
$2,245,000 30 Jun 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
6.7%
110,990
$1,259,000 30 Jun 2020
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
5.7%
94,370
$1,070,000 30 Jun 2020
13F
ExodusPoint Capital Management, LP
13F
Company
5.1%
83,502
$947,000 30 Jun 2020
13F
Soleus Capital Management, L.P.
13F
Company
3.7%
60,670
$687,000 30 Jun 2020
13F
NORTHERN TRUST CORP
13F
Company
3.2%
51,857
$587,000 30 Jun 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
3%
49,911
$566,000 30 Jun 2020
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
2.9%
47,830
$542,000 30 Jun 2020
13F
STATE STREET CORP
13F
Company
2.6%
42,441
$481,000 30 Jun 2020
13F
VANGUARD GROUP INC
13F
Company
2.1%
34,659
$393,000 30 Jun 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2%
33,154
$375,000 30 Jun 2020
13F
CAAS CAPITAL MANAGEMENT LP
13F
Company
1.8%
30,000
$340,000 30 Jun 2020
13F
FEDERATED HERMES, INC.
13F
Company
1.8%
30,000
$340,000 30 Jun 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.6%
25,600
$290,000 30 Jun 2020
13F
Blackstone Inc.
13F
Company
1.5%
25,000
$284,000 30 Jun 2020
13F
Pentwater Capital Management LP
13F
Company
1.4%
23,800
$270,000 30 Jun 2020
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
1.3%
20,621
$234,000 30 Jun 2020
13F
Ensign Peak Advisors, Inc
13F
Company
0.91%
15,000
$170,000 30 Jun 2020
13F
Bank of New York Mellon Corp
13F
Company
0.81%
13,248
$151,000 30 Jun 2020
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.74%
12,109
$137,000 30 Jun 2020
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.49%
8,000
$91,000 30 Jun 2020
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.38%
6,194
$70,000 30 Jun 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.2%
3,357
$38,000 30 Jun 2020
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.15%
2,513
$28,000 30 Jun 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.13%
2,084
$24,000 30 Jun 2020
13F
DEUTSCHE BANK AG\
13F
Company
0.11%
1,891
$21,000 30 Jun 2020
13F
UBS Group AG
13F
Company
0.1%
1,716
$19,000 30 Jun 2020
13F
MORGAN STANLEY
13F
Company
0.1%
1,583
$18,000 30 Jun 2020
13F
OSAIC HOLDINGS, INC.
13F
Company
0.1%
1,575
$18,000 30 Jun 2020
13F
STRS OHIO
13F
Company
0.07%
1,100
$12,000 30 Jun 2020
13F
Tower Research Capital LLC (TRC)
13F
Company
0.05%
804
$9,000 30 Jun 2020
13F
CITIGROUP INC
13F
Company
0.04%
723
$8,000 30 Jun 2020
13F
Legal & General Group Plc
13F
Company
0.04%
656
$7,000 30 Jun 2020
13F
Ameritas Investment Partners, Inc.
13F
Company
0.02%
363
$4,000 30 Jun 2020
13F
BANK OF MONTREAL /CAN/
13F
Company
0.02%
329
$4,000 30 Jun 2020
13F
US BANCORP \DE\
13F
Company
0.02%
300
$3,000 30 Jun 2020
13F

Institutional Holders of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) as of Q3 2020

As of 30 Sep 2020, Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,656,403 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, Polaris Venture Management Co. V, L.L.C., RA CAPITAL MANAGEMENT, L.P., ArrowMark Colorado Holdings LLC, Ikarian Capital, LLC, PURA VIDA INVESTMENTS, LLC, BlackRock Inc., Invesco Ltd., VANGUARD GROUP INC, and Soleus Capital Management, L.P.. This page lists 39 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
43
Q3 2020 holders
39
Holder diff
-4
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .